Skip to main content

Chronic Lower Limb Pain

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
1 program
AXIUM Neurostimulator SystemN/A1 trial
Active Trials
NCT01923285Completed152Est. Sep 2016
Neuronoff
NeuronoffOH - Cleveland
1 program
Neuronoff BASMATI InjectrodeN/A1 trial
Active Trials
NCT04672096Completed10Est. May 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NeuronoffNeuronoff BASMATI Injectrode
AbbottAXIUM Neurostimulator System

Clinical Trials (2)

Total enrollment: 162 patients across 2 trials

NCT04672096NeuronoffNeuronoff BASMATI Injectrode

Basic Assessment of Safety and Minimally Invasive Stimulation Via Injectrode

Start: Dec 2020Est. completion: May 202110 patients
N/ACompleted
NCT01923285AbbottAXIUM Neurostimulator System

A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain

Start: Aug 2013Est. completion: Sep 2016152 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.